Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1026 to 1050 of 2422

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Ambu aScope4 Broncho for use in unexpected difficult airwaysMTG14
Ocrelizumab for treating primary progressive multiple sclerosisTA585
Percutaneous insertion of a cerebral protection device to prevent cerebral embolism during TAVIIPG650
Percutaneous mechanical thrombectomy for acute deep vein thrombosis of the legIPG651
Bronchoscopic thermal vapour ablation for upper-lobe emphysemaIPG652
Endocuff Vision for assisting visualisation during colonoscopyMTG45
Physical activity: encouraging activity in the communityQS183
Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetesTA583
Atezolizumab in combination for treating metastatic non-squamous non-small-cell lung cancerTA584
The Sherlock 3CG Tip Confirmation System for placement of peripherally inserted central cathetersMTG24
Therapeutic hypothermia for acute ischaemic strokeIPG647
Collagen paste for closing an anal fistulaIPG648
Percutaneous mitral valve leaflet repair for mitral regurgitationIPG649
Hyperparathyroidism (primary): diagnosis, assessment and initial managementNG132
Inotersen for treating hereditary transthyretin amyloidosisHST9
Enzalutamide for hormone-relapsed non-metastatic prostate cancerTA580
Curos for preventing infections when using needleless connectorsMTG44
Lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary careDG35
DuraGraft for preserving vascular graftsMIB184
Crohn's disease: managementNG129
Ulcerative colitis: managementNG130
Intrapartum care for women with existing medical conditions or obstetric complications and their babiesNG121
Brentuximab vedotin for treating CD30-positive cutaneous T-cell lymphomaTA577
Certolizumab pegol for treating moderate to severe plaque psoriasisTA574
Bosutinib for untreated chronic myeloid leukaemia (terminated appraisal)TA576

Results per page

  1. 10
  2. 25
  3. 50
  4. All